International clamour over Germany’s seizure of Indian generics shipment
This article was originally published in SRA
Executive Summary
Another seizure of an Indian-manufactured generic drug by a customs authority in the European Union has fuelled concern that the EU’s enforcement of intellectual property rights regulations is delaying access to essential medicines in developing countries.